Skip to main content
Year archive

Medivir — 2018 filings

All 57 regulatory filings released by Medivir (MVIR) in 2018, sourced directly from the official regulator.

57 Filings
2018 Period
2018 filings (57)
Filing Released Lang
Första patienten med tjocktarmscancer doserad i Medivirs fas 2 studie av kombinationsbehandling med birinapant och Keytruda®
Regulatory Filings
2018-12-21 Swedish
First patient with colorectal cancer dosed in the Phase ll study of birinapant in combination with Keytruda®
Regulatory Filings
2018-12-21 English
The transformation into a company focused on clinical development of pharmaceuticals has now been completed and Medivir gives a project update
Regulatory Filings
2018-12-14 English
Omorganisationen till renodlat kliniskt läkemedelsutvecklingsbolag genomförd och Medivir lämnar projektuppdatering
Management Reports
2018-12-14 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-10-26 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-10-26 English
Medivir drar ner på forskningen för att fokusera på klinisk utveckling
Legal Proceedings Report
2018-10-17 Swedish
Medivir scales back research costs to focus on clinical development
Earnings Release FY 2018
2018-10-17 English
Medivir to focus on its clinical development and appoints Uli Hacksell as acting CEO
Board/Management Information
2018-10-15 English
Medivir fokuserar på klinisk utveckling och utser Uli Hacksell till tf vd
Board/Management Information
2018-10-15 Swedish
Positiva interimsdata för birinapant i kombinationsstudie med Keytruda®
Regulatory Filings
2018-10-04 Swedish
Positive interim data on birinapant in combination with Keytruda®
Regulatory Filings
2018-10-04 English
Klinisk fas I/II-studie av MIV-818 påbörjad i patienter med levercancer
Regulatory Filings
2018-10-01 Swedish
Phase I/II clinical study of MIV-818 started in patients with liver cancer
Regulatory Filings
2018-10-01 English
Medivir appoints Dr. Linda Basse as Chief Medical Officer
Board/Management Information
2018-09-10 English
Medivir utser Dr. Linda Basse till Chief Medical Officer
Board/Management Information
2018-09-10 Swedish
MIV-711 osteoarthritis phase IIa extension study outcomes show continuing positive effect on joint structure
Regulatory Filings
2018-07-27 English
Resultaten från fas IIa-fortsättningsstudien med MIV-711 för artros visar fortsatt positiv påverkan på ledstrukturer
Earnings Release FY 2017
2018-07-27 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-07-25 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-07-25 English
Medivir announces positive top-line results from the MIV-711 osteoarthritis phase IIa extension study
Regulatory Filings
2018-06-28 English
Medivir presenterar positiva topline resultat från fas IIa-fortsättningsstudien med MIV-711 för artros
Earnings Release FY 2017
2018-06-28 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-06-19 English
Fortsatt dialog med FDA medför att den planerade fas III-studien med remetinostat flyttas fram
Regulatory Filings
2018-06-18 Swedish
Continued discussions with FDA on proposed remetinostat phase III design results in delay in planned start of study
Regulatory Filings
2018-06-18 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-28 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-24 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-22 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-21 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-11 English
Resolutions at the Annual General Meeting in Medivir on 3 May 2018
AGM Information
2018-05-03 English
Beslut vid årsstämma i Medivir den 3 maj 2018
AGM Information
2018-05-03 Swedish
Number of shares and votes in Medivir
Share Issue/Capital Change
2018-04-30 English
Antal aktier och röster i Medivir
Declaration of Voting Results & Voting Rights Announcements
2018-04-30 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-27 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-27 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-04-05 English
Annual Report 2017
Annual Report FY 2017
2018-04-04 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-04 English
Notice of Annual General Meeting of Medivir AB (publ)
AGM Information
2018-04-04 English
Kallelse till årsstämma i Medivir AB (publ)
AGM Information
2018-04-04 Swedish
Samtliga A-aktier i Medivir omvandlas till B-aktier – prospekt offentliggörs
Share Issue/Capital Change
2018-03-28 Swedish
Conversion of all class A shares in Medivir to class B shares – prospectus published
Capital/Financing Update
2018-03-28 English
Medivirs Chief Medical Officer lämnar bolaget
Board/Management Information
2018-03-14 Swedish
Medivir Announces Departure of Chief Medical Officer
Board/Management Information
2018-03-14 English
Number of shares and votes in Medivir
Share Issue/Capital Change
2018-02-28 English
Antal aktier och röster i Medivir
Share Issue/Capital Change
2018-02-28 Swedish
Annual Report 2017
Annual Report FY 2017
2018-02-14 Swedish
Audit Report / Information 2017
Audit Report / Information FY 2017
2018-02-14 English
Medivir has completed a directed share issue of approximately 155 MSEK
Share Issue/Capital Change
2018-02-02 English
Medivir har genomfört en riktad nyemission om cirka 155 MSEK
Capital/Financing Update
2018-02-02 Swedish
Medivir intends to make a directed share issue
Share Issue/Capital Change
2018-02-01 English
Medivir avser att genomföra en riktad nyemission
Capital/Financing Update
2018-02-01 Swedish
Kallelse till extra bolagsstämma i Medivir AB (publ)
AGM Information
2018-01-02 Swedish
Notice of Extraordinary General Meeting of Medivir AB (publ)
AGM Information
2018-01-02 English
Medivir’s series A shares to be converted into series B shares
Share Issue/Capital Change
2018-01-02 English
A-aktierna i Medivir omvandlas till B-aktier
Declaration of Voting Results & Voting Rights Announcements
2018-01-02 Swedish